Related content

The Wnt Pathway as a Target for Small Synthetic Anti-Cancer Molecules

By  

Current Chemical Biology, Vol. 1, Iss. 2, 2007-05 ,pp. : 227-239

Bentham Science Publishers

Access to resources Recommend Favorite

The Anterior Gradient-2 Pathway as a Model for Developing Peptide-Aptamer Anti-Cancer Drug Leads that Stimulate p53 Function

By  

Current Chemical Biology, Vol. 3, Iss. 2, 2009-05 ,pp. : 124-137

Bentham Science Publishers

Access to resources Recommend Favorite

The Anterior Gradient-2 Pathway as a Model for Developing Peptide-Aptamer Anti-Cancer Drug Leads that Stimulate p53 Function

By Fourtouna Argyro   Murray Euan   Nicholson Judith   Maslon Magdalena M.   Pang Lisa Y.   Dryden David T.F.   Hupp Ted R.  

Current Opinion in Chemical Biology, Vol. 3, Iss. 2, 2009-05 ,pp. : 124-137

Elsevier

Access to resources Recommend Favorite

The promise of sulfated synthetic small molecules as modulators of glycosaminoglycan function

By Desai Umesh R  

Future Medicinal Chemistry, Vol. 5, Iss. 12, 2013-08 ,pp. : 1363-1366

Future Science

Access to resources Recommend Favorite

Regulation of the small regulatory RNA MicA by ribonuclease III: a target-dependent pathway

By Viegas Sandra C.   Silva Ins J.   Saramago Margarida   Domingues Susana   Arraiano Ceclia M.  

Nucleic Acids Research, Vol. 39, Iss. 7, 2011-04 ,pp. : 2918-2930

Oxford University Press

Access to resources Recommend Favorite